AT393221T

Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses

Abstract

(57) Summary book invention contains an antisense oligomer to bacterial 16S or 23S rRNA, and relates to the method for the composites which can adjust the biological activity alternatively, and those use. In details, more. Whether the present invention is found out in one or more specific bacteria, and Or it is related with the antisense oligomer to which it generally pointed to 16S or 23SrRNA which are saved between common bacteria, the pharmacological composite containing it, and the disposal method containing it.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

17 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
16815099United States of AmericaP

Members17

Family members, oldest first
DocumentOfficeKind
CA2392685A1CanadaA1
WO0142457A2World Intellectual Property Organization (WIPO)A2
AU4509801AAustraliaA
WO0142457A3World Intellectual Property Organization (WIPO)A3
US2002082226A1United States of AmericaA1
KR20020064915ARepublic of KoreaA
EP1238071A2European Patent Office (EPO)A2
JP2003516151AJapanA
US6677153B2United States of AmericaB2
US2004137485A1United States of AmericaA1
AU783874B2AustraliaB2
US7238675B2United States of AmericaB2
EP1238071B1European Patent Office (EPO)B1
AT393221TThis recordAustriaT
DE60038695D1GermanyD1
DE60038695T2GermanyT2
CA2392685CCanadaC